BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20601799)

  • 21. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Makrilia N; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):351-4. PubMed ID: 21737894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer and thrombosis. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Shah MM; Saif MW
    JOP; 2010 Jul; 11(4):331-3. PubMed ID: 20601805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy for pancreas cancer: advances and controversies.
    Mulcahy MF
    Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Merl MY; Li J; Saif MW
    JOP; 2010 Mar; 11(2):148-50. PubMed ID: 20208324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
    Kleeff J; Michalski CW; Friess H; Büchler MW
    Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
    Javle M; Hsueh CT
    J Hematol Oncol; 2009 Feb; 2():9. PubMed ID: 19236713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Lazenby JM; Saif MW
    JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant treatment of pancreatic cancer.
    Neoptolemos JP
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S378-80. PubMed ID: 21944022
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and adjuvant therapy for patients with pancreatic carcinoma.
    Clark JW; Glicksman AS; Wanebo HJ
    Cancer; 1996 Aug; 78(3 Suppl):688-93. PubMed ID: 8681308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
    Saif MW
    JOP; 2008 Jul; 9(4):391-7. PubMed ID: 18648128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Richter J; Saif MW
    JOP; 2010 Mar; 11(2):144-7. PubMed ID: 20208323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New techniques and agents in the adjuvant therapy of pancreatic cancer.
    Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
    Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern management of pancreatic carcinoma.
    Goldstein D; Carroll S; Apte M; Keogh G
    Intern Med J; 2004 Aug; 34(8):475-81. PubMed ID: 15317546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.